Taylor Wealth Management Partners Sells 3,942 Shares of CryoPort Inc (NASDAQ:CYRX)

Taylor Wealth Management Partners reduced its stake in CryoPort Inc (NASDAQ:CYRX) by 1.3% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 295,888 shares of the consumer goods maker’s stock after selling 3,942 shares during the quarter. CryoPort accounts for approximately 2.3% of Taylor Wealth Management Partners’ investment portfolio, making the stock its 20th largest holding. Taylor Wealth Management Partners’ holdings in CryoPort were worth $4,839,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Handelsinvest Investeringsforvaltning bought a new stake in shares of CryoPort in the second quarter valued at approximately $183,000. SG Americas Securities LLC acquired a new position in CryoPort during the second quarter valued at approximately $249,000. Marshall Wace LLP acquired a new position in CryoPort during the second quarter valued at approximately $282,000. Greenwood Capital Associates LLC raised its position in CryoPort by 5.8% during the second quarter. Greenwood Capital Associates LLC now owns 20,014 shares of the consumer goods maker’s stock valued at $367,000 after purchasing an additional 1,100 shares in the last quarter. Finally, Atria Investments LLC acquired a new position in CryoPort during the second quarter valued at approximately $404,000. Institutional investors and hedge funds own 59.59% of the company’s stock.

Several research analysts have commented on CYRX shares. Needham & Company LLC started coverage on shares of CryoPort in a research report on Monday, July 1st. They set a “buy” rating and a $22.00 price objective for the company. B. Riley set a $26.00 price objective on shares of CryoPort and gave the company a “buy” rating in a research report on Friday, July 19th. ValuEngine downgraded shares of CryoPort from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Svb Leerink restated an “outperform” rating on shares of CryoPort in a research report on Monday, July 15th. Finally, BidaskClub downgraded shares of CryoPort from a “sell” rating to a “strong sell” rating in a research report on Saturday, October 5th. One analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $24.00.

Shares of NASDAQ:CYRX traded up $0.64 during trading on Thursday, hitting $14.86. 21,049 shares of the company were exchanged, compared to its average volume of 870,221. The business’s 50 day moving average is $17.49 and its 200-day moving average is $17.69. The company has a market capitalization of $489.76 million, a P/E ratio of -47.48 and a beta of 0.81. The company has a quick ratio of 17.68, a current ratio of 17.73 and a debt-to-equity ratio of 0.17. CryoPort Inc has a 1-year low of $8.28 and a 1-year high of $25.02.

CryoPort (NASDAQ:CYRX) last announced its quarterly earnings results on Thursday, August 8th. The consumer goods maker reported ($0.08) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.08). The company had revenue of $8.46 million during the quarter, compared to the consensus estimate of $7.94 million. CryoPort had a negative net margin of 35.71% and a negative return on equity of 17.32%. The company’s revenue for the quarter was up 82.7% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.09) earnings per share. As a group, sell-side analysts anticipate that CryoPort Inc will post -0.3 earnings per share for the current year.

CryoPort Profile

CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers.

Further Reading: Is the QQQ ETF safe?

Want to see what other hedge funds are holding CYRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CryoPort Inc (NASDAQ:CYRX).

Institutional Ownership by Quarter for CryoPort (NASDAQ:CYRX)

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.